Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6453
Revised: August 12, 2013
Accepted: August 20, 2013
Published online: October 14, 2013
Processing time: 117 Days and 0.9 Hours
AIM: To investigate whether nonalcoholic fatty liver disease (NAFLD) affects coronary artery disease (CAD) and identify candidate mediators.
METHODS: Patients who underwent coronary angiography were consecutively recruited. The patients were classified into four groups by coronary artery stenosis: A, insignificant; B, one-vessel disease; C, two-vessel disease; and D, three-vessel disease. Abdominal ultrasonography was performed to determine the presence of a fatty liver and categorize by grade: 0, no evidence; 1, mild; 2, moderate; and 3, severe. We measured not only known CAD risk factors, but also serum insulin, HOMA-index, adiponectin, interleukin-6, tumor necrosis factor-α and high-sensitivity C-reactive protein levels.
RESULTS: Of the 134 patients who met the inclusion criteria, 82 (61.2%) had ultrasonographically diagnosed NAFLD. Among the 46 patients with CAD, 37 (80.4%) had evidence of a fatty liver. The two groups (A vs B-D) were significantly different in terms of age, total cholesterol, triglycerides, low-density lipoprotein levels and fatty liver. Coronary artery stenosis was strongly associated with fatty liver in a grade-dependent manner (P = 0.025). In binary logistic regression, NAFLD was a significant independent predictor of CAD (P = 0.03, OR = 1.685; 95%CI: 1.051-2.702). Among the candidate mediators, the serum adiponectin level showed a trend toward lowering based on CAD progression (P = 0.071).
CONCLUSION: NAFLD is an independent risk factor for CAD in a grade-dependent manner. Moreover, adiponectin might be related to the pathogenesis of NAFLD.
Core tip: This article shows that angiographically proven coronary artery stenosis is strongly associated with nonalcoholic fatty liver disease (NAFLD) in a grade-dependent manner. Although many recent studies used coronary artery calcification score, carotid artery intima-media thickness, or carotid artery plaque measurements as surrogate markers for coronary artery disease (CAD), we evaluated the interaction between fatty liver and cardiovascular outcomes using coronary angiograms in a prospective case-controlled study. Because the pathogenesis of NAFLD and CAD is not fully elucidated, we attempted to identify mediators of these diseases and believe that adiponectin might be related to the development and progression of CAD in patients with NAFLD.